Component

Human headache frequency during aspartame challenges

Context-specific entity; species, compartment and exposure are stated on each claim.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. An acute crossover challenge in 40 self-reported headache-sensitive adults found headaches in 35% after 30 mg/kg aspartame versus 45% after placebo.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Acute human challenge.
    limitations
    Different exposure duration from the repeated trial; no molecular mechanism identified.
    nutrient_topic
    Aspartame collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Aspartame
    plain_language
    Another blinded study did not reproduce increased headache frequency.
    primary_references
    Aspartame and susceptibility to headache. · 1987 · https://pubmed.ncbi.nlm.nih.gov/3657889/ · DOI 10.1056/NEJM198711053171903

    Aspartame: digestion, taste, metabolite dependencies and experimental signaling (2026-09-20) · lines 314–320

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Acute human challenge. · source_derived_draft · unverified_draft

    ## aspartame-headache-null Another blinded study did not reproduce increased headache frequency. An acute crossover challenge in 40 self-reported headache-sensitive adults found headaches in 35% after 30 mg/kg aspartame versus 45% after placebo. Model: Acute human challenge. Limitations: Different exposure duration from the repeated trial; no molecular mechanism identified. Evidence access: Primary abstract Aspartame and susceptibility to headache. · 1987 · https://pubmed.ncbi.nlm.nih.gov/3657889/ · DOI 10.1056/NEJM198711053171903
    Complete structured claim and evidence
  2. A repeated crossover trial reported headaches on 33% of aspartame days versus 24% of placebo days, P=0.04; 18 of 32 randomized participants completed all periods.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    About 30 mg/kg/day, seven-day periods; self-identified headache-sensitive volunteers.
    limitations
    No significant difference in headache duration or intensity; attrition and multiple analyses limit certainty.
    nutrient_topic
    Aspartame collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Aspartame
    plain_language
    A positive symptom finding comes with substantial missing follow-up.
    primary_references
    Aspartame ingestion and headaches: a randomized crossover trial. · 1994 · https://pubmed.ncbi.nlm.nih.gov/7936222/ · DOI 10.1212/wnl.44.10.1787

    Aspartame: digestion, taste, metabolite dependencies and experimental signaling (2026-09-20) · lines 306–312

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · About 30 mg/kg/day, seven-day periods; self-identified headache-sensitive volunteers. · source_derived_draft · unverified_draft

    ## aspartame-headache-positive A positive symptom finding comes with substantial missing follow-up. A repeated crossover trial reported headaches on 33% of aspartame days versus 24% of placebo days, P=0.04; 18 of 32 randomized participants completed all periods. Model: About 30 mg/kg/day, seven-day periods; self-identified headache-sensitive volunteers. Limitations: No significant difference in headache duration or intensity; attrition and multiple analyses limit certainty. Evidence access: Primary abstract Aspartame ingestion and headaches: a randomized crossover trial. · 1994 · https://pubmed.ncbi.nlm.nih.gov/7936222/ · DOI 10.1212/wnl.44.10.1787
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards